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‘New’ deviancy theories came to prominence during the 1960s and presented a 
significant challenge to established ways of thinking about crime, delinquency and other 
forms of rule-breaking. These theories dismissed the idea that there is a distinct, 
unambiguously deviant minority whose behavior can be explained as a result of 
individual pathology or social dysfunction. Instead, it was argued that deviance involves 
meaningful and goal-oriented behavior, which can only be understood through an 
appreciative stance that is committed to faithful understanding of the world as seen by 
the subject.  
 
Methods and Aims: 
This paper focuses on the application of ‘new’ deviancy theories to the progression from 
medically appropriate prescription drug use to extra-medical ‘abuse’. Special 




 ‘New’ deviancy theories lend valuable insights into contemporary patterns of 
unauthorized prescription drug use. They bring to light the role of the physician-patient 
interaction as a mechanism to diagnose ‘misuse’ by searching for use of neutralization 
techniques, and for its function in facilitating future ‘abuse’ by guiding a patient through 
the learned steps to become a regular user. They highlight the importance of values in a 
patient’s choice to accept medications with psychoactive side effects, and they reinforce 
the subjectivity in diagnosis and labeling misuse. These theories illustrate the 
complexities of the interplay between social welfare support, disability, societal norms 
and self-identity, which are all critical parts of the patient experience. Finally, these 
concepts help generate hypothesis about the development of meaningful subcultural 
groups based around this type of behavior. An appreciation of drug ‘abuse’ through this 
 4 
historical framework can inform new approaches for drug policy aimed at reducing 





 Although the ‘new’ deviancy theories are now more than 50 years old, they continue to 
inform our understanding of contemporary patterns of illicit drug use 1.  The lines 
between licit and illicit forms of drug use have become increasingly blurred since the 
‘new’ deviancy theories were developed: the ‘misuse’ of prescription opiate analgesics 
and the expansion of marihuana prescribing have pulled much of the discussion 
surrounding these activities into the medical sphere. It is our contention, that the 
application of classic sociological and criminological theory lends valuable insights into 
contemporary patterns of unauthorized prescription drug ‘abuse’.  
Deviance is a sociological concept that refers to behaviors and beliefs that deviate from 
the norms, standards and expectations of a given society1. It is a broader concept than 
crime and is distinct from the notion of ‘difference’ in that it contains the implicit 
likelihood of authoritative intervention or sanction: that is to say it refers to behaviors 
and beliefs that are stigmatized.  ‘New’ deviancy theories challenged established ways 
of thinking about such phenomena by rejecting the idea that there is a distinct, 
unambiguously deviant minority whose behavior can be explained as a result of 
individual pathology or social dysfunction. In place of the traditional ‘correctionalist’ 
orientation an ‘appreciative stance’ was advocated which is committed to faithful 
understanding of the world as seen by the subject. Viewed from this perspective, it was 
argued that deviance is meaningful behavior involving choice and that there is an 
underlying  continuity between normalcy and deviance 2. Such continuity is evident in 
the use of prescription medications,  which is deemed legitimate when it is authorised 
by a physician to treat a medical ailment, but is likely to be deemed deviant if the 
patient continues to use when there is no longer a medical need to do so – either for 
pleasure or because they have become dependenti.  
 
Howard Becker provided the most famous statement of the ‘new’ deviancy position 
when he noted that “deviance is not a quality of the act the person commits, but rather 
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a consequence of the application by others of rules ad sanctions to an ‘offender’: 
deviant behavior, in other words, “is behavior that people so label” 3.In his seminal work 
on, ‘Becoming a Marihuana User’, Becker describes a series of learned steps that he 
deemed necessary for someone to become a regular drug user: 
 
‘…No one becomes a user without 1 - learning to smoke the drug in a way which 
will produce real effects; 2 - learning to recognize the effects and connect them 
with the drug use (learning, in other words, to get high); and 3 - learning to enjoy 
the sensations he perceives.’ 4 
 
Due to the illegality of marihuana use throughout United States at the time, would-be 
users had to contend with powerful forces of social control. It was, Becker noted, by 
being a part of a user group that participants could gain access to supply, keep their use 
a secret and gain access to justifications and rationalizations. 
Use of prescription medications has many interesting contrasts and similarities with the 
processes Becker describes in relation to marihuana use. Marihuana and opiates have 
the potential to create both euphoric and dysphoric sensation. A physician may spend 
considerable effort educating a patient about the risks and benefits of the drug – 
helping them to perceive the effects and to make sense of the experience. In this way 
the informed-consent process replaces the role of the drug-user group described by 
Becker. As part of the process of guiding patients and helping them to learn how to use 
prescription drugs, we might infer that physicians might inadvertently facilitate the 
transition to ‘abuse’. From an ethical perspective two major principles of medical 
practice seem at odds; the principals of premum non nocere or ‘do no harm’ and 
‘patient autonomy ‘. In respecting one of these principles the physician violates the 
other. How such principles are understood might influence the way clinicians frame 
instructions for use, side effects and the risk profiles of prescription drugs.  
 
The role that rationalisations and justifications play in supporting deviant behavior was 
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famously highlighted by David Matza and Gresham Sykes5. Insisting that ‘juvenile 
delinquents’ do not subscribe to an oppositional morality, these authors argued that 
delinquencyis is motivated by exaggerated adherence to widely held subterranean 
values, emphasizing excitement and hedonistic leisure, over formal values and 
work.Matza and Sykes also highlighted the role that neutralization techniques play in 
sustaining deviant behavior by warding off the guilt associated with such activities 5. 
These techniques include denial of responsibility, denial of injury, denial of the victim, 
condemnation of the condemners, and appeals to higher loyalties. It follows that 
neutralization techniques only need to be applied when behavior is deviant, and always 
when it is illegal.  During the initiation of prescription medications, these techniques are 
unnecessary, but are likely to be activated if use progresses beyond the point of medical 
need. Based on this perspective one can assert that prescription use becomes deviant 
once the user needs to employ neutralization techniques: the use of such techniques 
signifies an implicit recognition that the behavior falls outside of what is considered 
legitimate or acceptable and is moving towards recreational use or dependency.  
Drawing on these insights, clinicians might consider assessing the use of neutralization 
techniques to diagnose ‘inappropriate’ drug use. Addressing patients’ assumptions and 
beliefs is already a core part of psychotherapy in the addictions.  Further, understanding 
the patient’s value system can help direct the informed-consent discussion to explicitly 
confront the sensation of feeling high as part of the side effect profile of these drugs  - 
especially with regards to opioids. 
 
Jock Young drew attention to the socially constructed nature of deviance in his book The 
Drugtakers6.  Adopting a relativist position, Young argued that the same activity might 
be labelled as simultaneously deviant and normal depending on whose standards are 
being applied. It is, in other words, the context surrounding the action as well as the 
larger societal norms that constructs the definition. This type of subjective assessment 
of deviancy has direct parallels with the interplay between physician and patient. It 
underscores some of the largest practical difficulties when labeling / diagnosing use, 
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‘misuse’ and ‘abuse’ – or, in the sociological rhetoric - deviancy. There is a dynamic 
context for drug use, at one moment it can be to treat pain alone, and another to enjoy 
the high or to meet a dependence, while many times it achieves all three. As with 
deviancy, the diagnoses of pain and/or dependency is subjective and context specific.  
 
Edwin Lemert’s distinction between primary and secondary deviance is pertinent here7. 
Highlighting the importance of social reaction, Lemert notes that primary deviance is 
commonplace and managed within a socially acceptable identity, while secondary 
deviance is internalised and becomes part of the core definition of the self. An example 
of secondary deviance would be when somebody who uses drugs comes to define 
themselves as an “addict”. Interaction with significant others is an important influence 
and may lead to the normalisation or acceptance of the deviation as peripheral to 
identity or may stimulate a symbolic reorganisation of the self around the deviant act. 
The distinction between primary and secondary deviance parallels exactly the transition 
from authorised use of medication to treat pain to viewing the use of the drug or the 
addiction as the pathology in-and-of-itself. Furthermore, Lemert describes secondary 
deviance as, ‘Adjustment to the overt and covert problems created by the consequent 
societal reaction to him’, which corresponds with the way modern welfare systems give 
social support to chronic patients due to their disability8. The chicken and egg debate 
about whether welfare support incentivizes/ creates long-term disability remains 
contentious9. 
 
Harold Finestone showed how addiction is shaped by the broader social context in his 
influential ethnographic study of black heroin users in 1960s Chicago. “With little 
prospect of achieving or identifying with status positions in larger society”, he argued, 
“the Cat [heroin user] is the personal counterpart of an expressive social movement” 10. 
According to Finestone, this form of secondary deviance was an expressive, productive 
adaptation to cope with systemic racism, segregation and exclusion from the formal 
economy. The heroin scene provided the basis of a countercultural identity built around 
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‘cool’ and ‘kicks’ as well as the need to ‘hustle’ (to maintain the lifestyle). For the Cat, 
the taboo and the desire to put himself beyond the comprehension of the ‘square’ were 
motivating and unifying10. The development of subcultures around prescription 
medications requires an ethnographic study of its own. 
 
 
‘New’ deviancy theories developed in opposition to the prevailing dogma that there was 
a deviant minority whose behavior could be explained as a result of intrinsic pathology 
or social dysfunction. Modern medical research tends to emphasize inherent pathology, 
neurochemical pathways, and social determination in much the same way as the very 
earliest deviancy theorist. Applying ‘new’ deviancy to this modern phenomenon can 
generate a novel understanding of the topic. The main contribution of the ‘new’ 
deviancy theories was to draw attention to the counter-productive nature of 
stigmatizing and exclusionary forms of social control: far from eliminating ‘deviance’ 
such responses often serve to entrench it. This does not mean that social control is 
necessarily a bad thing, however, and we would do well to heed the distinction 
Braithwaite draws between shaming that is stigmatising and counter-productive and 
that which is reintegrative and crime reducing11. Young made a similar distinction when 
he claimed ‘the subculture of drugtaking’ has ‘the only viable authority to control the 
activity of its members’. Rather than harassing and undermining existing drug 
subcultures, he advocated a policy of maintaining such cultures and encouraging users 
to adapt their habits by providing them with what he called 'positive propaganda' - 
accurate, credible information about the effect of drugs. Physicians treating patients 
whose use of prescription medication is blurring into recreational or dependent use are 
well placed to fulfill such a role. These lessons can guide policy makers seeking to 
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i The terms ‘problem drug use’ and ‘recreational drug’ use help to distinguish 
between different patterns of use, though the distinction between them may be 
blurred. Recreational drug use describes that which is geared towards pleasure or 
leisure, while problem use refers to that which results in social, psychological, 
and/or physical problems due intoxication, regular excessive use or dependence. 
The terms dependence and addiction are often used interchangeably and refer to “a 
state of duress where the individual’s freedom of choice over their drug has become 
impaired and the drug has begun to take control over their drug taking”. Addiction, 
according to the common medical definition, occurs (i) when there is increased 
tolerance for a drug (a given dose has a smaller effect); (ii) there are signs of 
physical and / or psychological dependence; and (iii) there are signs of withdrawal 
symptoms following sudden removal. Dependence is a broader concept which 
incorporates the key features of addiction alongside a range of psycho-social 
features and describes a strong, learnt, drug-seeking habit.   
 
